With the advent of genomic sequencing, we can finally decode and process our genetic makeup. We now have more data than ever before but providers don't have the infrastructure or expertise to make sense of said data. Here at Tempus, we believe the greatest promise for the detection and treatment of cancer lies in the deep understanding of molecular activity for disease initiation, progression, and efficacious treatment based on the discovery of unique biomarkers.
Tempus is looking for a hardworking, ambitious person to support its growing operations. Reporting to the Chief Financial Officer, this role will be responsible for leading the corporate development activities of Tempus. This includes: 1) leading and managing M&A activity, 2) analyzing industry trends and assessing competitive developments, 3) sizing market opportunities, and 4) leading and executing select strategic projects for the senior executives of Tempus. The candidate will work closely with leadership across the organization.